» Articles » PMID: 38576482

Aberrant Tumor Vasculature. Facts and Pitfalls

Overview
Journal Front Pharmacol
Date 2024 Apr 5
PMID 38576482
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial cells form a single cell layer lining the inner walls of blood vessels and play critical roles in organ homeostasis and disease progression. Specifically, tumor endothelial cells are heterogenous, and highly permeable, because of specific interactions with the tumor tissue environment and through soluble factors and cell-cell interactions. This review article aims to analyze different aspects of endothelial cell heterogeneity in tumor vasculature, with particular emphasis on vascular normalization, vascular permeability, metabolism, endothelial-to-mesenchymal transition, resistance to therapy, and the interplay between endothelial cells and the immune system.

Citing Articles

Amniotic membrane, a novel bioscaffold in cardiac diseases: from mechanism to applications.

Rayat Pisheh H, Darvishi A, Masoomkhah S Front Bioeng Biotechnol. 2025; 12:1521462.

PMID: 39758951 PMC: 11696288. DOI: 10.3389/fbioe.2024.1521462.


Leveraging the synergy between anti-angiogenic therapy and immune checkpoint inhibitors to treat digestive system cancers.

Xu Q, Shao D Front Immunol. 2024; 15:1487610.

PMID: 39691707 PMC: 11649667. DOI: 10.3389/fimmu.2024.1487610.

References
1.
Ribatti D, Pezzella F . Overview on the Different Patterns of Tumor Vascularization. Cells. 2021; 10(3). PMC: 8000806. DOI: 10.3390/cells10030639. View

2.
Rohlenova K, Goveia J, Garcia-Caballero M, Subramanian A, Kalucka J, Treps L . Single-Cell RNA Sequencing Maps Endothelial Metabolic Plasticity in Pathological Angiogenesis. Cell Metab. 2020; 31(4):862-877.e14. DOI: 10.1016/j.cmet.2020.03.009. View

3.
Dvorak H, Nagy J, Berse B, Brown L, Yeo K, Yeo T . Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci. 1992; 667:101-11. DOI: 10.1111/j.1749-6632.1992.tb51603.x. View

4.
McDonald D, Baluk P . Significance of blood vessel leakiness in cancer. Cancer Res. 2002; 62(18):5381-5. View

5.
Inai T, Mancuso M, Hashizume H, Baffert F, Haskell A, Baluk P . Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol. 2004; 165(1):35-52. PMC: 1618540. DOI: 10.1016/S0002-9440(10)63273-7. View